Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response

Title
Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response
Authors
Keywords
-
Journal
CANCER RESEARCH
Volume 76, Issue 6, Pages 1313-1319
Publisher
American Association for Cancer Research (AACR)
Online
2016-01-14
DOI
10.1158/0008-5472.can-15-1458

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More